Related by context. Frequent words. (Click for all words.) 72 MBP# [001] 61 Phase III Trial 61 confirmatory Phase III 60 relapsing forms 60 phase IIa 60 methylnaltrexone 60 relapsing remitting multiple sclerosis 58 PEG Interferon lambda 58 Phase 1b trial 58 diabetic neuropathic pain 58 Initiates Phase 58 Amigal 58 LymphoStat B 57 Phase Ib 57 Torisel 57 nitazoxanide 57 oral formulation 57 Phase 1b clinical 57 daclizumab 57 laquinimod 57 TELCYTA 56 PROMACTA 56 Phase 2b study 56 phase IIb 56 Cladribine Tablets 56 Phase 2b trial 56 HuMax CD# 56 valopicitabine 56 Phenoptin 56 ZYFLO CR 56 Acute Myeloid Leukemia AML 56 COPAXONE ® 56 TORISEL 56 voclosporin 56 LIALDA 56 velaglucerase alfa 56 Exalgo 56 davunetide 56 Phase IIa trial 56 VPRIV 55 tivozanib 55 Kuvan 55 HGS ETR1 55 relapsed multiple myeloma 55 dose regimens 55 TREANDA 55 PEG INTRON 55 dose cohorts 55 FOLOTYN 55 refractory multiple myeloma 55 PF # [001] 55 Naglazyme 55 MGCD# [001] 55 AVONEX 55 Phase IIa clinical 55 Phase III clinical 55 eltrombopag 55 vandetanib 55 lupus nephritis 55 Zerenex 54 Phase 2a trial 54 Phase IIb trial 54 sodium Injection 54 tamibarotene 54 BENLYSTA 54 FTY# 54 PXD# 54 elagolix 54 Santhera 54 Jevtana 54 iloperidone 54 cladribine 54 ecallantide 54 intravenous formulation 54 opioid induced constipation 54 Neupro ® 54 Mylotarg 54 tezampanel 54 investigational compounds 54 Betaferon 54 humanized monoclonal antibody 54 ridaforolimus 54 chronic angina 54 relapsing remitting MS 54 Phase 1b 54 ThermoDox ® 54 Phase 2a clinical 54 Cimzia ® 54 Taxotere ® 54 Betaseron 54 NGX# 53 Rivaroxaban 53 mipomersen 53 ARCALYST 53 teduglutide 53 ambrisentan 53 microRNA therapeutics 53 dosing regimens 53 investigational oral 53 Phase III clinical trials 53 blinded placebo controlled